IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

Iftekhar Khan

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

Population & Patient Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	International Journal of Radiation Oncology Biology Physics
Volume	95
Issue number	5
Publication status	Published - Aug 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b9cc2e850e874c9e99103a09f9487dc3,

title = "IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer",

author = "Iftekhar Khan",

year = "2016",

month = aug,

language = "English",

volume = "95",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

AU - Khan, Iftekhar

PY - 2016/8

Y1 - 2016/8

M3 - Article

SN - 0360-3016

VL - 95

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 5

ER -